Search

Search results

1. Canada should improve access to pharmaceuticals in post-COVID world

   Drugs were approved in the U.S. 469 days earlier (on average) than in Canada. ...

2. Timely Access to New Pharmaceuticals in Canada, the United States, and the European Union

   Modern medicines not only treat illnesses that could not previously be treated, but also represent a substitution for older, less efficient, and less effective methods of treatment. Newer medicines can expand access to better health through reductions in ...

3. Universal Insurance for Pharmaceuticals in Switzerland and the Netherlands

   Calls for government-operated universal drug insurance programs, commonly referred to as Pharmacare, can regularly be found in the nation’s media. These demands are often based on concerns about the affordability of prescription drugs, and typically call ...

4. Minister of health makes dubious claims about Ottawa’s pharmacare plan

   Appeared in the Hill Times, July 3, 2019 With the release of the Hoskins’ report last week, national pharmacare will likely be a central issue in this fall’s federal election. It’s therefore quite worrying that federal Health Minister Ginette Petitpas ...

5. Canada's free ride on U.S. drug development may end soon

   Appeared in the Moncton Times & Transcript, December 10, 2018 In October, the Trump administration outlined a plan that, if implemented, would substantially lower the amount the U.S. government will pay drug-makers for certain pharmaceuticals covered ...

6. Ontario’s new prescription drug plan misses the mark

   The recent announcement from Queen’s Park about a new program (called OHIP+) that will provide “free” prescription drugs for Ontarians under 25 is a misguided exercise in rebranding that sets a dangerous precedent for future policy. ...